Clinical Trial: Systemic Sclerosis Clinical and Biomarker Study

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Observational




Official Title: A Multicenter, Prospective, Longitudinal Study to Evaluate Gastrointestinal Function and Clinical and Molecular Biomarkers in Subjects With Early and Late Diffuse Cutaneous Systemic Sclerosis,

Brief Summary: The primary objective of the study is to assess the change in systemic sclerosis (SSc)-associated gastrointestinal (GI) tract symptoms over a 1-year period in participants with SSc.